📰 Largeb Cell News
Largeb Cell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Largeb Cell. Real-time updates on events, politics, business and more.
January 4, 2024
Partnership Will Utilize Foresight’s Ultra-Sensitive MRD Technology to Identify Patients for Enrollment in Allogene’s ALPHA3 Trial SAN FRANCISCO and BOULDER, Colo., Jan. 04, 2024 -- Allogene...
December 26, 2023
Fred Locke, MD shares his perspective on the future treatment paradigm in large B-cell lymphoma, emphasizing CAR-T cells, allogeneic strategies, bispecifics, toxicity management, and treatment sequencing.
December 12, 2023
Phase 1b DLBCL-001 study reinforces promising activity and combinability of golcadomide with R-CHOP in patients with previously untreated aggressive B-cell lymphoma Phase 1/2 CC-99282-NHL-001 study...
December 10, 2023
Recent decades have seen marked improvements in hematological cancer outcomes and an expanded armamentarium of therapies, but novel treatments require updated strategies that are not always easy to fine-tune, according to presenters at the 2023 American Society of Hematology Annual Meeting and Exposition.
December 6, 2023
Dr. Locke reviews the latest data from ZUMA-7 and TRANSFORM studies, evaluating CAR T in the second line setting for R/R LBCL.
December 5, 2023
Mary Louise Forseth, age 91, of Dodgeville, passed away at the Meadows Assisted Living and Memory Care Center in Spring Green, on Sunday, December 3, 2023. Mary was born on
November 30, 2023
SUNshine Girl Monika is a fighter and competitor in Muay Thai boxing. Though her biggest battle was beating mediastinal Large B-cell lymphoma cancer. (Jack…
November 30, 2023
SUNshine Girl Monika is a fighter and competitor in Muay Thai boxing. Though her biggest battle was beating mediastinal Large B-cell lymphoma cancer. (Jack…
November 30, 2023
SUNshine Girl Monika is a fighter and competitor in Muay Thai boxing. Though her biggest battle was beating mediastinal Large B-cell lymphoma cancer. (Jack…
November 2, 2023
Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populationsOral presentations highlighting new findings from a clinical trial of epcoritamab in patients with relapsed/refractory (R/R) dif...